Improved outcomes for Kaposi sarcoma using pegylated liposomal doxorubicin | Matthew Coldiron
1 مناظر
• 06/15/23
0
0
ایمبیڈ
administrator
سبسکرائبرز
A study conducted in Mozambique shows pegylated liposomal doxorubicin (PLD) was safe, well-tolerated and effective as first-line treatment for Kaposi’s sarcoma, a common HIV-associated malignancy.
مزید دکھائیں
فیس بک کے تبصرے
SORT BY-
سرفہرست تبصرے
-
تازہ ترین تبصرے